Cushing syndrome: Uncovering carney complex due to novel PRKAR1a mutation

8Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Carney complex (CNC) is a rare multiple neoplasia syndrome characterized by spotty pigmentation of the skin and mucosa in association with various non-endocrine and endocrine tumors, including primary pigmented nodular adrenocortical disease (PPNAD). A 20-year-old woman was referred for suspected Cushing syndrome. She had signs of cortisol excess as well as skin lentigines on physical examination. Biochemical investigation was suggestive of corticotropin (ACTH)- independent Cushing syndrome. Unenhanced computed tomography scan of the abdomen did not reveal an obvious adrenal mass. She subsequently underwent bilateral laparoscopic adrenalectomy, and histopathology was consistent with PPNAD. Genetic testing revealed a novel frameshift pathogenic variant c.488delC/p.Thr163MetfsX2 (ClinVar Variation ID: 424516) in the PRKAR1A gene, consistent with clinical suspicion for CNC. Evaluation for other clinical features of the complex was unrevealing. We present a case of PPNAD-associated Cushing syndrome leading to the diagnosis of CNC due to a novel PRKAR1A pathogenic variant.

Cite

CITATION STYLE

APA

Zhang, C. D., Pichurin, P. N., Bobr, A., Lyden, M. L., Young, W. F., & Bancos, I. (2019). Cushing syndrome: Uncovering carney complex due to novel PRKAR1a mutation. Endocrinology, Diabetes and Metabolism Case Reports, 2019(1). https://doi.org/10.1530/EDM-18-0150

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free